FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3014114144> ?p ?o ?g. }

• W3014114144 endingPage "3739" @default.
• W3014114144 startingPage "3732" @default.
• W3014114144 abstract "We performed next-generation sequencing (NGS) in the CONKO-001 phase III trial to identify clinically relevant prognostic and predictive mutations and conducted a functional validation in The Cancer Genome Atlas (TCGA) sequencing data.Patients of the CONKO-001 trial received curatively intended surgery for pancreatic adenocarcinoma (PDAC) followed by adjuvant chemotherapy with gemcitabine (Gem) or observation only (Obs). Tissue samples of 101 patients were evaluated by NGS of 37 genes. Cox proportional hazard models were applied for survival analysis. In addition, functional genomic analyses were performed in an NGS and RNA-sequencing dataset of 146 pancreatic tumors from TCGA.The most common mutations in the CONKO cohort were KRAS (75%), TP53 (60%), SMAD4 (10%), CDKNA2 (9%), as well as SWI/SNF (12%) complex alterations. In untreated patients, TP53 mutations were a negative prognostic factor for disease-free survival (DFS; HR mut vs. WT 2.434, P = 0.005). With respect to gemcitabine treatment, TP53 mutations were a positive predictive factor for gemcitabine efficacy [TP53mut: HR for DFS Gem vs. Obs, 0.235 (0.130 - 0.423; P < 0.001); TP53wt: HR for DFS Gem vs. Obs, 0.794 (0.417 - 1.513; P = 0.483)] with a significant test for interaction (P = 0.003). In the TCGA dataset, TP53 mutations were associated with shortened DFS.In CONKO-001, the benefit from adjuvant gemcitabine was confined to the TP53mut patient group. This potentially clinical relevant observation needs to be confirmed in independent prospective studies. The sensitivity of TP53mut PDAC to gemcitabine in CONKO-001 provides a lead for further mechanistic investigations." @default.
• W3014114144 created "2020-04-10" @default.
• W3014114144 creator A5002077225 @default.
• W3014114144 creator A5003729966 @default.
• W3014114144 creator A5006886614 @default.
• W3014114144 creator A5013965318 @default.
• W3014114144 creator A5015917994 @default.
• W3014114144 creator A5024665791 @default.
• W3014114144 creator A5031832059 @default.
• W3014114144 creator A5033698551 @default.
• W3014114144 creator A5046825627 @default.
• W3014114144 creator A5052578346 @default.
• W3014114144 creator A5055364430 @default.
• W3014114144 creator A5057927443 @default.
• W3014114144 creator A5058109622 @default.
• W3014114144 creator A5062511549 @default.
• W3014114144 creator A5066640097 @default.
• W3014114144 creator A5089035898 @default.
• W3014114144 date "2020-07-15" @default.
• W3014114144 modified "2023-10-15" @default.
• W3014114144 title "<i>TP53</i> Mutations Predict Sensitivity to Adjuvant Gemcitabine in Patients with Pancreatic Ductal Adenocarcinoma: Next-Generation Sequencing Results from the CONKO-001 Trial" @default.
• W3014114144 cites W1982840146 @default.
• W3014114144 cites W1987313243 @default.
• W3014114144 cites W2004446628 @default.
• W3014114144 cites W2069452349 @default.
• W3014114144 cites W2095893999 @default.
• W3014114144 cites W2096910745 @default.
• W3014114144 cites W2100421179 @default.
• W3014114144 cites W2129197203 @default.
• W3014114144 cites W2129769331 @default.
• W3014114144 cites W2131493705 @default.
• W3014114144 cites W2133707964 @default.
• W3014114144 cites W2135403187 @default.
• W3014114144 cites W2138582833 @default.
• W3014114144 cites W2157590016 @default.
• W3014114144 cites W2161884651 @default.
• W3014114144 cites W2164223424 @default.
• W3014114144 cites W2285093314 @default.
• W3014114144 cites W2414965726 @default.
• W3014114144 cites W2581973599 @default.
• W3014114144 cites W2713314794 @default.
• W3014114144 cites W2748710555 @default.
• W3014114144 cites W2808191072 @default.
• W3014114144 cites W2903623792 @default.
• W3014114144 cites W2904049988 @default.
• W3014114144 doi "https://doi.org/10.1158/1078-0432.ccr-19-3034" @default.
• W3014114144 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32234756" @default.
• W3014114144 hasPublicationYear "2020" @default.
• W3014114144 type Work @default.
• W3014114144 sameAs 3014114144 @default.
• W3014114144 citedByCount "26" @default.
• W3014114144 countsByYear W30141141442020 @default.
• W3014114144 countsByYear W30141141442021 @default.
• W3014114144 countsByYear W30141141442022 @default.
• W3014114144 countsByYear W30141141442023 @default.
• W3014114144 crossrefType "journal-article" @default.
• W3014114144 hasAuthorship W3014114144A5002077225 @default.
• W3014114144 hasAuthorship W3014114144A5003729966 @default.
• W3014114144 hasAuthorship W3014114144A5006886614 @default.
• W3014114144 hasAuthorship W3014114144A5013965318 @default.
• W3014114144 hasAuthorship W3014114144A5015917994 @default.
• W3014114144 hasAuthorship W3014114144A5024665791 @default.
• W3014114144 hasAuthorship W3014114144A5031832059 @default.
• W3014114144 hasAuthorship W3014114144A5033698551 @default.
• W3014114144 hasAuthorship W3014114144A5046825627 @default.
• W3014114144 hasAuthorship W3014114144A5052578346 @default.
• W3014114144 hasAuthorship W3014114144A5055364430 @default.
• W3014114144 hasAuthorship W3014114144A5057927443 @default.
• W3014114144 hasAuthorship W3014114144A5058109622 @default.
• W3014114144 hasAuthorship W3014114144A5062511549 @default.
• W3014114144 hasAuthorship W3014114144A5066640097 @default.
• W3014114144 hasAuthorship W3014114144A5089035898 @default.
• W3014114144 hasBestOaLocation W30141141441 @default.
• W3014114144 hasConcept C121608353 @default.
• W3014114144 hasConcept C126322002 @default.
• W3014114144 hasConcept C143998085 @default.
• W3014114144 hasConcept C207103383 @default.
• W3014114144 hasConcept C2780210213 @default.
• W3014114144 hasConcept C2780258809 @default.
• W3014114144 hasConcept C2781182431 @default.
• W3014114144 hasConcept C2781187634 @default.
• W3014114144 hasConcept C2992026798 @default.
• W3014114144 hasConcept C44249647 @default.
• W3014114144 hasConcept C526805850 @default.
• W3014114144 hasConcept C71924100 @default.
• W3014114144 hasConceptScore W3014114144C121608353 @default.
• W3014114144 hasConceptScore W3014114144C126322002 @default.
• W3014114144 hasConceptScore W3014114144C143998085 @default.
• W3014114144 hasConceptScore W3014114144C207103383 @default.
• W3014114144 hasConceptScore W3014114144C2780210213 @default.
• W3014114144 hasConceptScore W3014114144C2780258809 @default.
• W3014114144 hasConceptScore W3014114144C2781182431 @default.
• W3014114144 hasConceptScore W3014114144C2781187634 @default.
• W3014114144 hasConceptScore W3014114144C2992026798 @default.
• W3014114144 hasConceptScore W3014114144C44249647 @default.
• W3014114144 hasConceptScore W3014114144C526805850 @default.
• W3014114144 hasConceptScore W3014114144C71924100 @default.
• W3014114144 hasFunder F4320327569 @default.

• next